0001193805-23-001081.txt : 20230804
0001193805-23-001081.hdr.sgml : 20230804
20230804083729
ACCESSION NUMBER: 0001193805-23-001081
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230802
FILED AS OF DATE: 20230804
DATE AS OF CHANGE: 20230804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Errico Thomas J.
CENTRAL INDEX KEY: 0001737633
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38538
FILM NUMBER: 231142307
MAIL ADDRESS:
STREET 1: 150 ALLEN ROAD, SUITE 201
CITY: BASKING RIDGE
STATE: NJ
ZIP: 97920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: electroCore, Inc.
CENTRAL INDEX KEY: 0001560258
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 203454976
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 FORGE WAY
STREET 2: SUITE 205
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
BUSINESS PHONE: 973-290-0097
MAIL ADDRESS:
STREET 1: 200 FORGE WAY
STREET 2: SUITE 205
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
FORMER COMPANY:
FORMER CONFORMED NAME: ElectroCore, LLC
DATE OF NAME CHANGE: 20121012
4
1
e618829_4-errico.xml
X0508
4
2023-08-02
0
0001560258
electroCore, Inc.
ECOR
0001737633
Errico Thomas J.
200 FORGE WAY, SUITE 205
ROCKAWAY
NJ
07866
1
0
0
0
0
Common Stock
2023-08-02
4
A
0
45607
4.35
A
167867
D
Warrants to Purchase Common Stock
4.35
2023-08-02
4
P
0
22803
0.0625
A
2024-02-02
2029-02-02
Common Stock
22803
22803
D
On August 2, 2023, pursuant to a private placement offering by the Issuer, the Reporting Person acquired 45,607 Units, each Unit consisting of (i) one share of the Issuer's Common Stock and (ii) one Warrant to purchase one-half share of the Issuer's Common Stock. The combined purchase price in the Offering was $4.4125 per Unit, inclusive of $4.35 per share of Common Stock and $0.0625 per Warrant. Each Warrant entitles the holder thereof to purchase one half of a share of Common Stock, is exercisable beginning six months from the date of issuance at an exercise price of $4.35 per share, and expires five years from the initial exercise date.
Consists of 150,023 shares of common stock beneficially owned directly by the Reporting Person; 1,296 shares of common stock beneficially owned by a trust for the benefit of the Reporting Person's family members; and 13,732 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested and unvested shares were previously reported on Form 4 filings at the time of grant.
/s/ John L. Cleary, II, attorney-in-fact
2023-08-04